Global Demand For Immunity Probiotics Boosts Chr. Hansen
Executive Summary
Ingredients specialist Chr. Hansen cites the global COVID-19 pandemic for driving up demand for probiotics in supplements and infant formula globally.
You may also be interested in...
Chr. Hansen Bets On Rising Demand For Probiotics With UAS Labs Deal
Rising global demand for probiotics is the motivating factor behind Chr Hansen's $530m acquisition of US dietary supplements player UAS Laboratories.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.